Biomarkers and Genomic Testing
Tools You Can Use
Liquid Biopsy/ctDNA Testing: Signatera
Liquid Biopsy/ctDNA (for MRD) Testing: Guardant Reveal
Liquid Biopsy/ctDNA Testing: Guardant360®
Tissue Testing: Immunoscore®
Questions? Feedback?

What is Guardant360® CDx?

Guardant360 CDx is a liquid biopsy test that provides the answers your doctor needs to build your treatment plan. 

As a blood test, Guardant360 CDx captures the DNA that is shed from your tumor. This provides a comprehensive overview of your cancer genomics from both your primary tumor and any metastatic sites. Guardant360 CDx examines 50+ clinically relevant genes to identify select genomic biomarkers specific to your cancer, while avoiding the complications and delays of a tissue biopsy.

Introduction to Guardant360 CDx from Guardant Health

When should Guardant360 CDx be considered?

Your doctor may order Guardant360 CDx for advanced cancer:

  • On initial diagnosis
  • If testing of your initial tissue biopsy is incomplete or inconclusive
  • If your cancer is progressing on the current treatment

For the complete intended use statement, visit

Disclaimer: Data shown for the performance of Guardant360 Laboratory Developed Test (LDT) does not convey the performance of Guardant360 CDx.

Questions about Guardant360?
Call 855.698.8887 or email [email protected]